Have your own idea? Try our Stock Screener
French (CAC) Biotech Industry Analysis
UpdatedFeb 07, 2026
DataAggregated Company Financials
Companies22
- 7D1.0%
- 3M12.8%
- 1Y303.3%
- YTD-10.9%
In the last week, the Biotech industry is flat overall, with DBV Technologies standing out by going down 4.5%. The past year has been better, since the industry has gained 303% in that time. As for the next few years, earnings are expected to grow by 54% per annum.
Industry Valuation and Performance
Has the French Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 08 Feb 2026 | €10.8b | €559.4m | -€763,099,265.39 | 14x | -14.2x | 19.3x |
| Tue, 06 Jan 2026 | €10.8b | €641.8m | -€694,415,439.50 | 9.8x | -15.6x | 16.8x |
| Thu, 04 Dec 2025 | €2.5b | €636.8m | -€430,723,847.64 | 10.6x | -5.8x | 3.9x |
| Sat, 01 Nov 2025 | €2.5b | €639.5m | -€422,026,921.38 | 9.9x | -6x | 4x |
| Mon, 29 Sep 2025 | €2.3b | €643.5m | -€455,630,522.89 | 16x | -5x | 3.6x |
| Wed, 27 Aug 2025 | €2.3b | €674.2m | -€446,135,666.45 | 15.3x | -5.3x | 3.5x |
| Fri, 25 Jul 2025 | €2.2b | €655.5m | -€451,381,871.43 | 15.2x | -4.8x | 3.3x |
| Sun, 22 Jun 2025 | €1.9b | €666.6m | -€496,176,815.36 | 17.4x | -3.9x | 2.9x |
| Tue, 20 May 2025 | €2.4b | €674.0m | -€677,006,770.55 | 15.8x | -3.5x | 3.5x |
| Thu, 17 Apr 2025 | €2.2b | €650.6m | -€550,949,902.73 | 13.8x | -4x | 3.4x |
| Sat, 15 Mar 2025 | €2.3b | €664.3m | -€478,938,745.38 | 16.6x | -4.8x | 3.4x |
| Mon, 10 Feb 2025 | €2.4b | €650.5m | -€528,033,806.72 | 16.3x | -4.6x | 3.7x |
| Wed, 08 Jan 2025 | €2.4b | €650.4m | -€527,537,113.32 | 18.4x | -4.6x | 3.7x |
| Fri, 06 Dec 2024 | €2.4b | €654.1m | -€547,438,320.91 | 18.1x | -4.3x | 3.6x |
| Sun, 03 Nov 2024 | €2.8b | €640.1m | -€520,393,708.60 | 18.4x | -5.4x | 4.4x |
| Tue, 01 Oct 2024 | €2.9b | €640.8m | -€509,661,401.72 | 19.6x | -5.6x | 4.5x |
| Thu, 29 Aug 2024 | €3.1b | €520.4m | -€579,707,921.16 | 36.8x | -5.3x | 6x |
| Sat, 27 Jul 2024 | €2.9b | €511.7m | -€566,628,871.32 | 28.6x | -5.2x | 5.7x |
| Mon, 24 Jun 2024 | €2.9b | €514.4m | -€569,641,165.19 | 26.4x | -5.1x | 5.7x |
| Wed, 22 May 2024 | €3.3b | €502.4m | -€592,772,441.57 | 28x | -5.6x | 6.6x |
| Fri, 19 Apr 2024 | €3.2b | €515.7m | -€629,383,997.10 | 27.2x | -5.1x | 6.2x |
| Sun, 17 Mar 2024 | €3.1b | €567.9m | -€645,920,503.60 | 21.2x | -4.8x | 5.5x |
| Tue, 13 Feb 2024 | €3.0b | €558.9m | -€674,993,364.48 | 22.4x | -4.5x | 5.4x |
| Thu, 11 Jan 2024 | €3.1b | €594.2m | -€682,964,552.00 | 23.5x | -4.6x | 5.3x |
| Sat, 09 Dec 2023 | €3.2b | €594.8m | -€686,243,538.00 | 21.8x | -4.7x | 5.4x |
| Mon, 06 Nov 2023 | €3.3b | €803.4m | -€564,493,061.00 | 21.2x | -5.9x | 4.1x |
| Wed, 04 Oct 2023 | €3.3b | €831.5m | -€577,467,092.00 | 14.1x | -5.7x | 4x |
| Fri, 01 Sep 2023 | €3.8b | €818.2m | -€726,786,328.00 | 23.8x | -5.3x | 4.7x |
| Sun, 30 Jul 2023 | €3.8b | €817.6m | -€735,190,518.00 | 24.7x | -5.2x | 4.6x |
| Tue, 27 Jun 2023 | €3.8b | €819.9m | -€743,854,281.00 | 25.3x | -5.1x | 4.6x |
| Thu, 25 May 2023 | €3.7b | €826.4m | -€769,320,253.00 | 25.4x | -4.8x | 4.5x |
| Sat, 22 Apr 2023 | €3.5b | €877.8m | -€752,665,368.00 | 31.8x | -4.6x | 4x |
| Mon, 20 Mar 2023 | €3.3b | €1.0b | -€480,608,887.00 | 9.5x | -6.8x | 3.2x |
| Wed, 15 Feb 2023 | €3.7b | €1.0b | -€456,667,662.00 | 11.4x | -8x | 3.5x |
Price to Earnings Ratio
-8x
Current Industry PE
- Investors are optimistic on the French Biotechs industry, and appear confident in long term growth rates.
- The 3-year average PS ratio of 5.1x is lower than the industry's current PS ratio of 19.3x.
Past Earnings Growth
- The earnings for companies in the Biotechs industry have deteriorated over the last three years.
- Revenues have also declined 19% per year.
- This means overall sales from these companies are declining and losses are subsequently expanding as well.
Industry Trends
Which industries have driven the changes within the French Healthcare industry?
| FR Market | 1.22% | |
| Healthcare | -0.37% | |
| Biotech | 0.96% | |
| Biotech | 0.96% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| ABVX ABIVAX Société Anonyme | €96.90 | 2.2% +€163.4m | 1,597.0% | PS1420x | |
| VLA Valneva | €4.03 | 3.6% +€25.6m | 28.9% | PS3.9x | |
| GNFT Genfit | €6.10 | 8.8% +€24.6m | 62.5% | PS6.7x | |
| NANO Nanobiotix | €17.94 | 2.7% +€23.2m | 363.6% | PS85.4x | |
| MAAT MaaT Pharma | €6.90 | -5.5% €12.3m | -8.0% | PS33.1x |
